Overview
- An Inserm-coordinated study has implanted the experimental device in 38 patients worldwide to assess its benefits and limits.
- The system couples a glasses-mounted camera with a 2 cm intraocular implant that receives infrared signals and sends electrical cues to the brain.
- Clinicians emphasize that the device delivers a reconstructed image from the camera rather than restoring natural vision.
- Reported improvements do not enable driving or unassisted street navigation, and the protocol requires lengthy rehabilitation.
- Eligibility is narrow, focusing on motivated candidates roughly ages 75–80 in good health, as dry AMD remains incurable and affects more than 1.5 million people in France.